Promising research findings show how artificial intelligence can support the detection of breast cancer.
The Artificial Intelligence (AI) division of Google based in London, DeepMind, will attempt to differentiate between healthy and cancerous tissue by analysing 700 CT and MRI scans from former Universi
New drugs designed by artificial intelligence could be in clinical trials as soon as later this year.
ECR research highlights potential of AI in breast cancer imaging using DCE-MRI. Read on for more!